tiprankstipranks
Trending News
More News >
Profound Medical (PROF)
NASDAQ:PROF
US Market

Profound Medical (PROF) Financial Statements

Compare
79 Followers

Profound Medical Financial Overview

Profound Medical's market cap is currently $252.50M. The company's EPS TTM is $-0.26; its P/E ratio is -5.22; Profound Medical is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 10.68MC$ 7.20MC$ 6.68MC$ 6.87MC$ 7.30M
Gross ProfitC$ 7.04MC$ 4.38MC$ 3.02MC$ 2.95MC$ 3.47M
Operating IncomeC$ -33.06MC$ -28.62MC$ -29.60MC$ -30.29MC$ -18.86M
EBITDAC$ -32.13MC$ -27.00MC$ -34.63MC$ -28.65MC$ -19.50M
Net IncomeC$ -27.82MC$ -28.57MC$ -28.67MC$ -30.70MC$ -21.62M
Balance Sheet
Cash & Short-Term InvestmentsC$ 54.91MC$ 26.21MC$ 46.52MC$ 67.15MC$ 83.91M
Total AssetsC$ 70.23MC$ 43.91MC$ 64.42MC$ 86.78MC$ 104.60M
Total DebtC$ 5.12MC$ 7.87MC$ 8.23MC$ 1.38MC$ 1.68M
Net DebtC$ -49.79MC$ -18.35MC$ -38.29MC$ -65.78MC$ -82.24M
Total LiabilitiesC$ 9.81MC$ 12.73MC$ 12.42MC$ 6.16MC$ 7.25M
Stockholders' EquityC$ 60.42MC$ 31.18MC$ 52.00MC$ 80.62MC$ 97.35M
Cash Flow
Free Cash FlowC$ -23.45MC$ -22.30MC$ -25.80MC$ -22.95MC$ -20.92M
Operating Cash FlowC$ -23.45MC$ -22.30MC$ -25.80MC$ -22.36MC$ -20.57M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ -593.00KC$ -350.00K
Financing Cash FlowC$ 54.70MC$ 1.46MC$ 7.03MC$ 5.95MC$ 87.43M
Currency in CAD

Profound Medical Earnings and Revenue History

Profound Medical Debt to Assets

Profound Medical Cash Flow

Profound Medical Forecast EPS vs Actual EPS